Anavex Life Sciences Corp. (AVXL): EPS (Basic)
-$0.54
Year ended 2025-09-30
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$0.54 | n/m | 2026-08-28, From 2024-10-01 |
| 2024-09-30 | -$0.52 | n/m | 2026-08-28, From 2023-10-01 |
| 2023-09-30 | -$0.60 | n/m | 2026-08-28, From 2022-10-01 |
| 2022-09-30 | -$0.62 | n/m | 2023-11-27, From 2021-10-01 |
| 2021-09-30 | -$0.54 | n/a | 2023-11-27, From 2020-10-01 |
| No annual figure between 2016-09-30 and 2021-09-30. | |||
| 2016-09-30 | -$0.42 | n/m | 2016-12-14, From 2015-10-01 |
| 2015-09-30 | -$0.65 | n/m | 2016-12-14, From 2014-10-01 |
| 2014-09-30 | -$1.02 | n/c | 2016-12-14, From 2013-10-01 |
| 2013-09-30 | -$0.12 | n/a | 2014-12-29, From 2012-10-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Anavex Life Sciences Corp. (AVXL) | 2025-09-30 | -$0.54 | n/m |
| Surrozen, Inc. (SRZN) | 2025-12-31 | -$32.37 | n/m |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | -$0.28 | n/m |
| Zura Bio Ltd (ZURA) | 2025-12-31 | -$1.06 | n/m |
| Quince Therapeutics, Inc. (QNCX) | 2025-12-31 | -$1.68 | n/m |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | -$0.80 | n/m |
| Humacyte, Inc. (HUMA) | 2025-12-31 | -$0.26 | n/m |
| LeonaBio, Inc. (LONA) | 2025-12-31 | -$24.70 | n/m |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | -$2.45 | n/m |
Compare AVXL, SRZN, LCTX, ZURA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗